An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report

被引:0
作者
Pichler, Franz B. [1 ]
Boysen, Meindert [2 ]
Mittmann, Nicole [3 ]
Gilardino, Ramiro [4 ]
Bruce, Andrew [5 ]
Bond, Kenneth [6 ]
Vreman, Rick A. [7 ]
Largeron, Nathalie [8 ]
Banhazi, Judit [9 ]
Ollendorf, Daniel A. [10 ]
Jain, Mohit [11 ]
Upadhyaya, Sheela [12 ]
Goettsch, Wim G. [13 ]
机构
[1] Confluence Hlth Consulting, Sydney, NSW, Australia
[2] Natl Inst Hlth & Care Excellence NICE, London, England
[3] Canadian Agcy Drugs & Technol Healthcare, Ottawa, ON, Canada
[4] MSD, Zurich, Switzerland
[5] Amgen Inc, Sydney, NSW, Australia
[6] Inst Hlth Econ, Edmonton, AB, Canada
[7] Roche, Utrecht, Netherlands
[8] Sanofi, Paris, France
[9] Menarini, Zurich, Switzerland
[10] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
[11] BioMarin, London, England
[12] Life Sci Consultant, London, England
[13] Zorginst Nederland ZIN, Utrecht, Netherlands
关键词
Operationalization; lifecycle; checklist; practical; guidance; examples; sequencing; criteria;
D O I
10.1017/S0266462324000199
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Operationalization guidance is needed to support health technology assessment (HTA) bodies considering implementing lifecycle HTA (LC-HTA) approaches. The 2022 Health Technology Assessment International (HTAi) Global Policy Forum (GPF) established a Task Force to develop a position paper on LC-HTA. In its first paper, the Task Force established a definition and framework for LC-HTA in order to tailor it to specific decision problems. This second paper focused on the provision of practical operational guidance to implement LC-HTA. Detailed descriptions of the three LC-HTA operational steps are provided (defining the decision problem, sequencing of HTA activities, and developing optimization criteria) and accompanied by worked examples and an operationalization checklist with 20 different questions for HTA bodies to consider when developing an LC-HTA approach. The questions were designed to be applicable across different types of HTA and scenarios, and require adaptation to local jurisdictions, remits, and context.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] Intrinsic properties of medical devices: considerations for economic evaluation
    Basu, Rituparna
    Eggington, Simon
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (06) : 619 - 626
  • [2] Data Analysis and Real World Interrogation Network (DARWIN EU), About us
  • [3] Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America
    Gilardino, Ramiro E.
    Mejia, Aurelio
    Guarin, Diego
    Rey-Ares, Lucila
    Perez, Ana
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 6 - 12
  • [4] Haute Autorite de Sante, 2021, Autorisation for early access to medicinal products: HTA assessment doctrine
  • [5] Reported Challenges in Health Technology Assessment of Complex Health Technologies
    Hogervorst, Milou A.
    Vreman, Rick A.
    Mantel-Teeuwisse, Aukje K.
    Goettsch, Wim G.
    [J]. VALUE IN HEALTH, 2022, 25 (06) : 992 - 1001
  • [6] What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
    Kc, Sarin
    Lin, Lydia Wenxin
    Bayani, Diana Beatriz Samson
    Zemlyanska, Yaroslava
    Adler, Amanda
    Ahn, Jeonghoon
    Chan, Kelvin
    Choiphel, Dechen
    Genuino-Marfori, Anne Julienne
    Kearney, Brendon
    Liu, Yuehua
    Nakamura, Ryota
    Pearce, Fiona
    Prinja, Shankar
    Pwu, Raoh-Fang
    Shafie, Arsul Akmal
    Sui, Binyan
    Suwantika, Auliya
    Tunis, Sean
    Wu, Hui-Min
    Zalcberg, John
    Zhao, Kun
    Isaranuwatchai, Wanrudee
    Teerawattananon, Yot
    Wee, Hwee-Lin
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2023, 12
  • [7] A Conceptual Framework for Life-Cycle Health Technology Assessment
    Kirwin, Erin
    Round, Jeff
    Bond, Ken
    McCabe, Christopher
    [J]. VALUE IN HEALTH, 2022, 25 (07) : 1116 - 1123
  • [8] HEALTH TECHNOLOGY REASSESSMENT: THE ART OF THE POSSIBLE
    MacKean, Gail
    Noseworthy, Tom
    Elshaug, Adam G.
    Leggett, Laura
    Littlejohns, Peter
    Berezanski, Joan
    Clement, Fiona
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (04) : 418 - 423
  • [9] Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?
    Merlin, Tracy
    Street, Jackie
    Carter, Drew
    Afzali, Hossein Haji Ali
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (06) : 823 - 830
  • [10] Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines
    Moseley, Jane
    Vamvakas, Spiros
    Berntgen, Michael
    Cave, Alison
    Kurz, Xavier
    Arlett, Peter
    Acha, Virginia
    Bennett, Simon
    Cohet, Catherine
    Corriol-Rohou, Solange
    Du Four, Emma
    Lamoril, Christelle
    Langeneckert, Anja
    Koban, Maren
    Paste, Muriel
    Sandler, Susan
    Van Baelen, Karin
    Cangini, Agnese
    Garcia, Sonia
    Obach, Merce
    Gimenez Garcia, Emmanuel
    Varela Lema, Leonor
    Jauhonen, Hanna-Mari
    Rannanheimo, Piia
    Morrison, Deborah
    Van De Casteele, Marc
    Stromgren, Anna
    Viberg, Anders
    Makady, Amr
    Guilhaume, Chantal
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1034 - 1051